BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35636577)

  • 1. Mechanisms of CD8+ T-cell failure in chronic hepatitis E virus infection.
    Kemming J; Gundlach S; Panning M; Huzly D; Huang J; Lütgehetmann M; Pischke S; Schulze Zur Wiesch J; Emmerich F; Llewellyn-Lacey S; Price DA; Tanriver Y; Warnatz K; Boettler T; Thimme R; Hofmann M; Fischer N; Neumann-Haefelin C
    J Hepatol; 2022 Oct; 77(4):978-990. PubMed ID: 35636577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E.
    Soon CF; Behrendt P; Todt D; Manns MP; Wedemeyer H; Sällberg Chen M; Cornberg M
    J Hepatol; 2019 Oct; 71(4):673-684. PubMed ID: 31203151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8
    Karimzadeh H; Kiraithe MM; Kosinska AD; Glaser M; Fiedler M; Oberhardt V; Salimi Alizei E; Hofmann M; Mok JY; Nguyen M; van Esch WJE; Budeus B; Grabowski J; Homs M; Olivero A; Keyvani H; Rodríguez-Frías F; Tabernero D; Buti M; Heinold A; Alavian SM; Bauer T; Schulze Zur Wiesch J; Raziorrouh B; Hoffmann D; Smedile A; Rizzetto M; Wedemeyer H; Timm J; Antes I; Neumann-Haefelin C; Protzer U; Roggendorf M
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution of hepatitis E virus infection in CD8+ T cell-depleted rhesus macaques.
    Bremer W; Blasczyk H; Yin X; Salinas E; Grakoui A; Feng Z; Walker C
    J Hepatol; 2021 Sep; 75(3):557-564. PubMed ID: 33961939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8
    Karimzadeh H; Kiraithe MM; Oberhardt V; Salimi Alizei E; Bockmann J; Schulze Zur Wiesch J; Budeus B; Hoffmann D; Wedemeyer H; Cornberg M; Krawczyk A; Rashidi-Alavijeh J; Rodríguez-Frías F; Casillas R; Buti M; Smedile A; Alavian SM; Heinold A; Emmerich F; Panning M; Gostick E; Price DA; Timm J; Hofmann M; Raziorrouh B; Thimme R; Protzer U; Roggendorf M; Neumann-Haefelin C
    Gastroenterology; 2019 May; 156(6):1820-1833. PubMed ID: 30768983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis D Virus-Specific CD8
    Kefalakes H; Koh C; Sidney J; Amanakis G; Sette A; Heller T; Rehermann B
    Gastroenterology; 2019 May; 156(6):1805-1819.e9. PubMed ID: 30664876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Chronic hepatitis E virus Infection in an individual without evidence for immune deficiency.
    Ying D; Niu W; Chen Y; Wang Y; Tian W; Zhang X; Liu C; Wang S; Chen Z; Lin Y; Guo S; Yu Z; Chen X; Fang M; Qiang H; Yin Y; Tang Z; Zheng Z; Fu L; Xia N
    Front Immunol; 2023; 14():1183859. PubMed ID: 37404820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient formation and maintenance of humoral and CD4 T-cell immunity targeting the viral capsid in acute-resolving hepatitis E infection.
    Csernalabics B; Marinescu MS; Maurer L; Kelsch L; Werner J; Baumann K; Zoldan K; Panning M; Reuken P; Bruns T; Bengsch B; Neumann-Haefelin C; Hofmann M; Thimme R; Dao Thi VL; Boettler T
    J Hepatol; 2024 Apr; 80(4):564-575. PubMed ID: 38154741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus.
    Brown A; Halliday JS; Swadling L; Madden RG; Bendall R; Hunter JG; Maggs J; Simmonds P; Smith DB; Vine L; McLaughlin C; Collier J; Bonsall D; Jeffery K; Dunachie S; Klenerman P; Izopet J; Kamar N; Dalton HR; Barnes E
    Hepatology; 2016 Dec; 64(6):1934-1950. PubMed ID: 27631819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection.
    Suneetha PV; Pischke S; Schlaphoff V; Grabowski J; Fytili P; Gronert A; Bremer B; Markova A; Jaroszewicz J; Bara C; Manns MP; Cornberg M; Wedemeyer H
    Hepatology; 2012 Mar; 55(3):695-708. PubMed ID: 22006345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection.
    Neumann-Haefelin C; Timm J; Spangenberg HC; Wischniowski N; Nazarova N; Kersting N; Roggendorf M; Allen TM; Blum HE; Thimme R
    Hepatology; 2008 Jun; 47(6):1824-36. PubMed ID: 18454507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatiotemporal Differences in Presentation of CD8 T Cell Epitopes during Hepatitis B Virus Infection.
    Khakpoor A; Ni Y; Chen A; Ho ZZ; Oei V; Yang N; Giri R; Chow JX; Tan AT; Kennedy PT; Maini M; Urban S; Bertoletti A
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic hepatitis E virus infection in a cirrhotic patient: A case report.
    Barragué H; Condat B; Petitdidier N; Champagne E; Renou C; Izopet J; Abravanel F
    Medicine (Baltimore); 2017 Sep; 96(39):e7915. PubMed ID: 28953614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetramer enrichment reveals the presence of phenotypically diverse hepatitis C virus-specific CD8+ T cells in chronic infection.
    Nitschke K; Flecken T; Schmidt J; Gostick E; Marget M; Neumann-Haefelin C; Blum HE; Price DA; Thimme R
    J Virol; 2015 Jan; 89(1):25-34. PubMed ID: 25320295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
    Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
    Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis E virus-induced primary cutaneous CD30(+) T cell lymphoproliferative disorder.
    Mallet V; Bruneau J; Zuber J; Alanio C; Leclerc-Mercier S; Roque-Afonso AM; Kraft ARM; Couronné L; Roulot D; Wedemeyer H; Albert ML; Hillon P; Laroche L; Pol S; Hermine O
    J Hepatol; 2017 Dec; 67(6):1334-1339. PubMed ID: 28860025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-B*27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope.
    Nitschke K; Barriga A; Schmidt J; Timm J; Viazov S; Kuntzen T; Kim AY; Lauer GM; Allen TM; Gaudieri S; Rauch A; Lange CM; Sarrazin C; Eiermann T; Sidney J; Sette A; Thimme R; López D; Neumann-Haefelin C
    J Hepatol; 2014 Jan; 60(1):22-9. PubMed ID: 23978718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity.
    Cao D; Cao QM; Subramaniam S; Yugo DM; Heffron CL; Rogers AJ; Kenney SP; Tian D; Matzinger SR; Overend C; Catanzaro N; LeRoith T; Wang H; Piñeyro P; Lindstrom N; Clark-Deener S; Yuan L; Meng XJ
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):6914-6923. PubMed ID: 28630341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune escape pathways from the HBV core
    Walker A; Schwarz T; Brinkmann-Paulukat J; Wisskirchen K; Menne C; Alizei ES; Kefalakes H; Theissen M; Hoffmann D; Schulze Zur Wiesch J; Maini MK; Cornberg M; Kraft AR; Keitel V; Bock HH; Horn PA; Thimme R; Wedemeyer H; Heinemann FM; Luedde T; Neumann-Haefelin C; Protzer U; Timm J
    Front Immunol; 2022; 13():1045498. PubMed ID: 36439181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.